Pharming reported a gross margin of 86.97% and a net margin of -2.20% for the quarter ended Jun 2026. These financial ratios cover 25 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2019 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||
| Gross Margin | 88.64% | 89.91% | 89.48% | 92.02% | 95.76% | 92.52% | 90.42% | 159.63% | 87.56% | 91.26% | 84.89% | 152,917,678.81% | 90.91% | 88.66% | 89.51% | 92.70% | 80.19% | 90.89% | 86.97% | ||||||
| EBT Margin | -37.16% | 13.73% | 9.87% | 35.53% | 17.16% | 21.92% | -38.40% | -24.20% | 4.96% | -14.79% | -28.92% | -22,515,519.57% | 2.02% | -7.43% | -14.53% | 13.05% | 4.51% | -6.02% | -1.05% | ||||||
| EBIT Margin | -3.19% | -15.69% | 6.01% | 35.53% | 14.39% | 18.81% | -32.12% | 9.65% | 2.86% | 1.35% | -29.32% | -26,225,371.12% | 5.48% | -7.48% | -8.85% | 16.24% | 5.82% | -6.77% | -2.21% | ||||||
| EBITDA Margin | -3.19% | -15.69% | 6.01% | 35.53% | 14.39% | 18.81% | -32.12% | 9.65% | 2.86% | 1.35% | -29.32% | -26,225,371.12% | 5.48% | -7.48% | -8.85% | 16.24% | 5.82% | -6.77% | -2.21% | ||||||
| Operating Margin | -3.19% | 18.45% | 6.01% | 35.53% | 14.39% | 18.81% | -32.12% | 9.65% | 2.86% | 1.35% | -29.32% | -26,225,371.12% | 5.48% | -7.48% | -8.85% | 16.24% | 5.82% | -6.77% | -2.21% | ||||||
| Net Margin | -33.83% | 16.30% | 11.59% | 43.09% | 17.53% | 25.10% | -48.90% | -28.57% | 4.73% | -16.60% | -22.39% | -18,442,645.07% | 15.26% | -5.79% | -18.61% | -2.87% | 5,048,826.29% | -7.20% | -2.20% | ||||||
| FCF Margin | 14.30% | 0.05% | 23.91% | 1.31% | -57.23% | 5.51% | -19.54% | -27,765,182.19% | 13.51% | -0.49% | 10,756,807.51% | -4.54% | |||||||||||||
| Efficiency | |||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 24.70M | 12.56M | 14.82M | 31.77M | 16.98M | 21.18M | 45.23M | 50.58M | 53.24M | 55.10M | 56.32M | 57.54M | 60.71M | 58.98M | 57.53M | 66.02M | 64.74M | 65.00M | |||||||
| Assets AverageAssets Avg. | 406.39M | 200.67M | 196.60M | 393.35M | 197.14M | 213.09M | 424.40M | 426.40M | 433.14M | 449.66M | 452.26M | 428.80M | 420.72M | 412.75M | 401.59M | 240.60M | 275.89M | 486.89M | 494.70M | 478.70M | |||||
| Invested CapitalInvested Cap. | 193.99M | 0.36M | 194.18M | 199.82M | 0.34M | 279.91M | 216.82M | ||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.60 | 1.19 | 1.23 | 0.62 | 1.24 | 1.42 | 0.70 | 0.71 | 0.73 | 0.55 | 0.57 | 0.47 | 0.50 | 0.81 | 0.89 | 1.65 | 0.78 | 0.50 | 0.69 | ||||||
| Leverage & Solvency | |||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | 2.79 | ||||||||||||||||||||||||
| Debt Ratio | 0.00 | 0.41 | 0.00 | 0.00 | 0.37 | 0.18 | -0.01 | ||||||||||||||||||
| Times Interest Earned | 2.79 | ||||||||||||||||||||||||
| Dividends & Payouts | |||||||||||||||||||||||||
| Dividend Coverage RatioDiv. Cover | 0.34 | -0.68 | 0.89 | 0.45 | |||||||||||||||||||||
| FCF Payout RatioFCF Cover | -0.69 | 1.07 | |||||||||||||||||||||||
| Dividend YieldDiv. Yield | -0.82% | -0.64% | -0.50% | -0.81% | |||||||||||||||||||||
| Payout Ratio | 2.91 | -1.46 | 1.13 | 2.22 | |||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||
| Price to EarningsP/E | -34.08 | 38.19 | 108.00 | 26.33 | 67.20 | 19.10 | -42.60 | -48.74 | 237.54 | -56.92 | -58.44 | -41.00 | 48.50 | -57.80 | -38.69 | -353.57 | 230.59 | -223.98 | -272.62 | ||||||
| Price to SalesP/S | 11.53 | 6.22 | 12.52 | 11.34 | 11.78 | 4.79 | 20.83 | 13.93 | 11.22 | 9.45 | 13.08 | 7.56M | 7.40 | 3.35 | 7.20 | 10.14 | 11.64M | 16.13 | 5.99 | ||||||
| Price to BookP/B | 3.14 | 0.00M | 3.01 | 2.85 | 0.00M | 3.54 | 4.44 | 3.82 | 3.56 | 3.51 | 3.53 | 2.54 | 2.45 | 3.10 | 2.64 | 3.73 | 4.47 | 4.34 | 3.60 | ||||||
| Enterprise Value | 422.58M | 579.56M | 393.33M | 378.13M | 446.44M | 516.61M | 701.07M | 572.27M | 550.67M | 553.61M | 525.47M | 400.02M | 381.87M | 516.50M | 414.63M | 728.24M | 820.28M | 1,024.97M | 878.00M | 815.13M | |||||
| EV to EBIT | -251.81 | -39.62 | 140.47 | 21.24 | 57.24 | 18.19 | -51.31 | 107.98 | 288.61 | 503.28 | -32.24 | -20.58 | 93.14 | -33.76 | -59.23 | 51.92 | 165.32M | -179.18 | -226.55 | ||||||
| EV to EBITDA | -251.81 | -39.62 | 140.47 | 21.24 | 57.24 | 18.19 | -51.31 | 107.98 | 288.61 | 503.28 | -32.24 | -20.58 | 93.14 | -33.76 | -59.23 | 51.92 | 165.32M | -179.18 | -226.55 | ||||||
| Market Capitalization | 606.88M | 579.98M | 583.23M | 568.30M | 638.37M | 723.95M | 886.07M | 764.65M | 748.24M | 767.04M | 727.44M | 560.35M | 553.64M | 684.39M | 569.42M | 738.14M | 986.45M | 1,239.87M | 1,167.60M | 974.63M | |||||
| Price to FCFP/FCF | 80.62 | 0.01M | 49.26 | 364.71 | -24.34 | 203.66 | -48.35 | -27.24 | 54.77 | -680.99 | 108.23 | -131.97 | |||||||||||||
| EV to FCF | 56.14 | 0.01M | 34.45 | 260.26 | -18.21 | 149.88 | -34.90 | -19.44 | 37.78 | -513.93 | 89.47 | -110.38 | |||||||||||||
| EV to CFO | 76.71 | 82.08 | 35.39 | 848.29 | -17.66 | 156.13 | -32.00 | -19.17 | 39.20 | -287.74 | 95.73 | -105.78 | |||||||||||||
| Return Ratios | |||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -3.19% | -15.69% | 6.01% | 35.53% | 14.39% | 18.81% | -32.12% | 9.65% | 2.86% | 1.35% | -29.32% | -26,225,371.12% | 5.48% | -7.48% | -8.85% | 16.24% | 5.82% | -6.77% | -2.21% | ||||||
| Return on Capital Employed [ROCE]ROCE | 14.23% | 0.42% | -1.75% | 1.25% | 6.99% | 37.03% | 11.04% | 7.70% | 6.01% | -1.44% | -3.26% | -9.38% | -8.96% | -13.85% | -11.61% | -1.28% | -1.75% | 1.02% | 1.89% | ||||||
| Return on Invested Capital [ROIC]ROIC | 24.55% | 0.90% | -1.74% | 2.08% | 13.05% | 46.53% | |||||||||||||||||||
| Return on Assets [ROA]ROA | 10.15% | 10.07% | 7.63% | 6.20% | 26.21% | 34.91% | 11.35% | 2.56% | 1.05% | -10.41% | -10.24% | -11.73% | -11.75% | -12.52% | -9.91% | -0.79% | -1.27% | 1.13% | 2.96% |